drug
as of 2026-07-01Modified diabetes prevention protocol & Metformin
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Hamilton Health Sciences Corporation
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BEHAVIORAL
Indications
Investigational (via trials)
Trials
1
Diabetes Prevention Program in Schizophrenia [DPPS]
NCT00182494Phase 4Unknown
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Lakshmi P Voruganti, MD
personKOL score —